UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells

European journal of clinical investigation, 2009-09, Vol.39 (9), p.813-818

2009

Volltextzugriff (PDF)

Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot study

European review for medical and pharmacological sciences, 2013-01, Vol.17 (2), p.224

2013

Volltextzugriff (PDF)

Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines

Leukemia, 2008-03, Vol.22 (3), p.628-631

2008

Volltextzugriff (PDF)

PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells

Leukemia research, 2008-01, Vol.32 (1), p.103-112

2008

Volltextzugriff (PDF)

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

Bone marrow transplantation (Basingstoke), 2003-07, Vol.32 (1), p.57-63

2003

Volltextzugriff (PDF)

Skin and stomach graft versus host disease after syngeneic BMT in CML: A case report

Leukemia research, 2007-11, Vol.31 (11), p.1603-1604

2007

Volltextzugriff (PDF)

Copper(II) and zinc(II) dinuclear enzymes model compounds: The nature of the metal ion in the biological function

Journal of molecular structure, 2017-12, Vol.1150, p.316-328

2017

Volltextzugriff (PDF)

The Efficacy of Rituximab plus Hyper-CVAD Regimen in Mantle Cell Lymphoma Is Independent of FCγRIIIa and FCγRIIa Polymorphisms

Journal of chemotherapy (Florence), 2007-06, Vol.19 (3), p.315-321

2007

Volltextzugriff (PDF)

Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2006-05, Vol.37 (9), p.897-898

2006

Volltextzugriff (PDF)

O42 WT1 gene expression is significantly inhibited by vorinostat and bortezomib

Blood reviews, 2007, Vol.21, p.S80-S80

2007

Volltextzugriff (PDF)

Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (8), p.859-861

2004

Volltextzugriff (PDF)

Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis

European journal of haematology, 2004-01, Vol.72 (1), p.45-51

2004

Volltextzugriff (PDF)

A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings

Bone marrow transplantation (Basingstoke), 2004-03, Vol.33 (6), p.659-660

2004

Volltextzugriff (PDF)

Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib

European journal of clinical investigation, 2004-03, Vol.34 (3), p.243-244

2004

Volltextzugriff (PDF)

The Clinical Relevance of the Expression of Several Multidrug-Resistant-Related Genes in Patients with Primary Acute Myeloid Leukemia

Journal of chemotherapy (Florence), 2003-08, Vol.15 (4), p.374-379

2003

Volltextzugriff (PDF)

Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: A clinical, neuroradiological and virological response after treatment with risperidone

Antiviral research, 2007-05, Vol.74 (2), p.156-158

2007

Volltextzugriff (PDF)

Early Reappearance of Primary Solid Cancer in Patients Treated With Purine Analogs

Journal of chemotherapy (Florence), 2003-08, Vol.15 (4), p.406-408

2003

Volltextzugriff (PDF)

Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia

Bone marrow transplantation (Basingstoke), 1999-08, Vol.24 (3), p.345-348

1999

Volltextzugriff (PDF)

Oral Cyclophosphamide Therapy for Patients with Residual or Relapsed Indolent-Type Lymphoma after Initial Treatment for Aggressive Lymphomas. A Sub-group of Patients with Apparent Transformed Indolent Lymphoma

Leukemia & lymphoma, 2002, Vol.43 (9), p.1803-1806

2002

Volltextzugriff (PDF)

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation

Leukemia research, 2005-08, Vol.29 (8), p.961-966

2005

Volltextzugriff (PDF)

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

European journal of haematology, 2004-12, Vol.73 (6), p.412-417

2004

Volltextzugriff (PDF)

Unusual morphology in a case of large granular cell leukemia

Annals of hematology, 2001-12, Vol.80 (12), p.755-757

2001

Volltextzugriff (PDF)

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients

Leukemia research, 2004-04, Vol.28 (4), p.367-372

2004

Volltextzugriff (PDF)

Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA

Journal of cellular biochemistry, 2004-12, Vol.93 (6), p.1231-1241

2004

Volltextzugriff (PDF)

Vorinostat and bortezomib significantly inhibit WT1 gene expression in M07-e and P39 cell lines

Leukemia, 2008-03, Vol.22 (3), p.628

2008

Volltextzugriff (PDF)

1 – 25 von 277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(191)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells

Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot study

Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines

PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

Skin and stomach graft versus host disease after syngeneic BMT in CML: A case report

Copper(II) and zinc(II) dinuclear enzymes model compounds: The nature of the metal ion in the biological function

The Efficacy of Rituximab plus Hyper-CVAD Regimen in Mantle Cell Lymphoma Is Independent of FCγRIIIa and FCγRIIa Polymorphisms

Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemia

O42 WT1 gene expression is significantly inhibited by vorinostat and bortezomib

Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor

Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis

A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings

Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib

The Clinical Relevance of the Expression of Several Multidrug-Resistant-Related Genes in Patients with Primary Acute Myeloid Leukemia

Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: A clinical, neuroradiological and virological response after treatment with risperidone

Early Reappearance of Primary Solid Cancer in Patients Treated With Purine Analogs

Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia

Oral Cyclophosphamide Therapy for Patients with Residual or Relapsed Indolent-Type Lymphoma after Initial Treatment for Aggressive Lymphomas. A Sub-group of Patients with Apparent Transformed Indolent Lymphoma

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

Unusual morphology in a case of large granular cell leukemia

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients

Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA

Vorinostat and bortezomib significantly inhibit WT1 gene expression in M07-e and P39 cell lines

Suchergebnisse filtern